UK markets closed

Grifols, S.A. (GRF.MC)

MCE - MCE Delayed price. Currency in EUR
Add to watchlist
19.88-0.03 (-0.15%)
At close: 05:35PM CEST
Sign in to post a message.
  • K
    I deposited $1000 into my Bitcoin wallet and Mr Samu haber trade it for me and i got first payout of $5000 in 3days ..I can now understand why they’re so many recommendations about him and i am also recommending his services to you reading this post..Don’t miss out. You can contact him What*sapp✅✅ +1 (619) 512‑8061 via Tele 👉✅✅@samuhaber3
  • J
    It's strange how people talk about all the profit they have been making through trading of Bitcoin while I'm here not making any profit at all.Can someone put me through on the right path.
  • B
    I'm no expert in trading but have made $35,000 within $1500 investment, I had good guidance within Mr Charlie shrem and his team, it's beyond eye opening with his teaching and skills. I've nothing but continued success...
    reach him👇👇👇
    Wha✅ts✅App  +1 (513)  810 9614 te✅le✅gr✅am.@Charlieshrem07
  • E
    God almighty had been doing great things in my life but the greatest he did was to have connected me to this Trader that has turn my life around. Some months ago I started investing with JeffWalton and it was very successful I was able to earn over 34,000$ weekly.. with an investment of 6000$ it been so amazing trading and investing with JeffWalton platform reach him Wh**atsApp +1 (706) 514‑2518 with the trading skills and strategy given to me by Mr JeffWalton His methods are top notch and profitable and He also can be contacted easily on te~le-gram~~~ @JeffWalton2
  • T
    The Egalitarian
    I could be bullish however, I’m cautious, as the P/E ratio of 88 is high. Why are all these investors mentioning their investing gurus, as this isn’t normal or welcomed when posting on stocks!
  • S
    What’s causing the jump?
  • b
    I don't think that GRFS has another 10% in gains in it. Looks pretty bad here. I actually found ( the other day and their stocks are way better...
  • l
    GRFS. is in a good position as the largest plasma collector and already has a contract with BARDA:

    Early Results Promising for Convalescent Plasma for COVID-19

    By Kelly Young

    Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

    A small, preliminary case series in JAMA shows promise for using convalescent plasma to treat critically ill patients with novel coronavirus disease (COVID-19).

    Researchers in China treated five COVID-19 patients who required mechanical ventilation and had severe pneumonia and high viral load despite taking antivirals. Plasma donors had recovered from SARS-CoV-2 infection and had been symptom-free for at least 10 days. Recipients received 400 mL of convalescent plasma containing neutralizing antibody.

    Within a day of the transfusion, markers of viral load began to improve. All patients saw gradual resolution of pulmonary lesions within 3 days. By day 9, four patients no longer required respiratory support. Three of the patients had been discharged after stays of roughly 50 days. The other two were still hospitalized.

    The authors and editorialists note that the results need to be validated in clinical trials. Last week, the FDA allowed physicians to apply for emergency use of investigational convalescent plasma to treat individual patients.


    JAMA article on convalescent plasma (Free)

    JAMA editorial (Free)

    FDA information on investigational convalescent plasma (Free)

    NEJM COVID-19 page (Free)
    NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
    NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
  • l
    Big article in STAT yesterday that the US multi-institutional consortium study on the benefits of convalescent plasma for sick patients with CV19 was strongly suggestive of efficacy; unfortunately, it was not a randomized placebo controlled study. The formal paper is awaiting publication. Under BARDA auspices, convalescent plasma is being converted into immunoglobulin(powder) which enables standardization from batch to batch, and allows for easier storage and administration. The GRFS product has already begun a ph3 study for CV19, both for prophylaxis for exposed individuals and as Rx for sick patients. The chances of success are excellent. The purest play on this theme is GRFS, which is a 15bil market cap biomedical company which specializes in plasma collection and plasma based theraputics. GRFS is one of the few biomedical companies which has failed to get a boost from CV19 and a +ph3 study almost certainly will lead to explosive growth. I am a heavy buyer today. Incidentally, I am a hematologist who did 2 years of immunology research on antibody therapy at NIH
  • G
    i just bought some shares. the earnings estimates are on the upswing and the company is at 52 week low. the dividend is nice and supportable. i think it is a good time to buy some shares.
  • N
    Nasdaq Quarterback
    I'm a true long here.. Been in the options for a long time. Based on my data this will move by Sept with a bigger move for November followed by Jan/Feb.
  • G
    I bought GRFS today at 11.99. Seems cheap…. I think it will make a comeback. Might take some time but I’m in now.
  • G
    from my readings, analysts dont like the stock because they are worried the company is over leveraged and took on too much debt. they are worried about the biotest acquisition as well. grfs needed to suspend the dividend to help shore up the balance sheet. ok - that is the negative side. on positive side, if they can successfully absorb biotest and generate a decent return on their investment, and shore up their balance sheet over the next year- this can turn out to be a decent investment. i think it is cheap turnaround play here. gl
  • A
    I think this will go up tomorrow due to Trumps FDA plasma news
  • G
    does grfs still pay a dividend? i haven't heard of a cut ..
  • A
    A Singapore wealth fund becomes a strategic investor by investing $1 billion to acquire a minority stake in a Grifols subsidiary with 300 U.S. plasma centers that will remain under Grifols management
  • O
    President Donald Trump on Sunday will announce the emergency authorization of convalescent plasma for Covid-19, according to the Washington Post and other reports.
    President Donald Trump on Sunday will announce the emergency authorization of convalescent plasma for Covid-19, according to the Washington Post and other reports.
  • G
    some companies trading at nosebleed levels .this company is cheaply priced. why does it go lower? no sense at all